Nystatin Interferes with the Effects of N-Methyl-N′-nitro-N-nitrosoguanidine on Sphingolipid Metabolism in Human FL Cells
Nystatin Interferes with the Effects of N-Methyl-N′-nitro-N-nitrosoguanidine on Sphingolipid Metabolism in Human FL Cells
复制标题
制霉菌素干扰 N-甲基-N′-硝基-N-亚硝基胍对人 FL 细胞鞘脂代谢的影响
DOI:
10.1007/s11745-008-3209-y
复制
发表时间:
2008
期刊:
影响因子:
1.9
通讯作者:
Jun Yang
中科院分区:
文献类型:
--
作者:
Guangyi Liu;Weimin Wang;Gongping Sun;Xiaoqiong Ma;Ziyang Liu;Jun Yang
Previously we have shown that an alkylating agent N-methyl-N′-nitro-N- nitrosoguanidine (MNNG) can induce receptor clustering and the activation of a downstream signal molecule NF-κB, and that the receptor clustering is associated with changes in sphingolipids metabolism. On the other hand, the polyene antibiotic nystatin can block MNNG-induced receptor clustering. In this study, using a lipidomic approach, we further evaluated whether nystatin influenced the effects of MNNG on sphingolipids metabolism. It was found that nystatin itself induced changes in the sphingolipids profile in human amnion FL cells to a certain extent, including an increase or decrease of some sphingolipid species. Interestingly, nystatin can block, at least partially, the changes of sphingolipids-induced by MNNG. In addition, nystatin can also partially inhibit the activation of NF-κB induced by MNNG. Neither MNNG nor nystatin affects the mRNA levels of serine palmitoyltransferase, acid sphingomyelinase (ASM), and sphingomyelin synthase, key enzymes in the sphingolipids biosynthesis pathway. However, MNNG can activate ASM and neutral sphingomyelinase, while nystatin preincubation inhibits the activation. Taken together, these data suggested that nystatin interferes with the effects of MNNG, and might elicit its function through altered sphingolipids metabolism.
影响因子:
--
作者:
Han,Xianlin
通讯作者:
Han,Xianlin
影响因子:
3.7
作者:
Huang,Yun;Shen,Jing;Wang,Ting;Yu,Yan-Ke;Chen,FanqingF;Yang,Jun
通讯作者:
Yang,Jun